Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Tissue Regenix Launches DermaPure In US; Stock Climbs

Shares of Tissue Regenix Group Plc (TRX.L) climbed around 18 percent in the morning trading in London after the British regenerative medical devices company announced that it has launched DermaPure, its decellularised dermis product, in the US.

Tissue Regenix's partner Community Tissue Services or CTS will begin shipping product to customers next week.

DermaPure is initially being targeted at acute care patients with diabetic foot ulcers. The company noted that the commercial launch of the DermaPure dermis allograft will now allow Tissue Regenix to target a market worth $1.4 billion a year for wound healing devices and equipment.

Tissue Regenix said its DermaPure works by taking human donor skin and removing the DNA and cells, using the patented dCELL process to leave a natural biological scaffold that can be placed in the wound to aid natural healing by attracting the patient's own cells to the wound area.

Tissue Regenix noted that its patented decellularisation or dCELL technology removes DNA and other cellular material from animal and human tissue leaving an acellular.

In addition to the launch of DermaPure, the company announced that it has continued to expand its distribution network around the country and currently has a network of over 60 reps that covers 80 percent of the US.

In addition, Tissue Regenix has signed an exclusive government supplier partnership with TASSMA for the distribution of DermaPure. The partnership with TASSMA will allow Tissue Regenix to immediately target the Department of Veteran's Affairs Healthcare System and the numerous branches of the US military, the company noted.

Greg Bila, President of Tissue Regenix Wound Care Inc. said, "Commercial production and distribution of the DermaPure is a significant step forward for Tissue Regenix. This paves the way for the development of other human tissue based medical treatments." In London, Tissue Regenix shares are currently trading at 24.15 pence, up 3.65 pence or 17.80 percent.

Register
To receive FREE breaking news email alerts for Tissue Regenix Group plc and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Stocks moved notably higher over the course of the trading day on Friday after initially showing a lack of direction. The gains on the day extended the recent upward trend by the markets, with the tech-heavy Nasdaq reaching its best closing level in almost a month. Looking to capitalize on news of an Ebola diagnosis in New York City, Republican Senate candidate Scott Brown issued a statement Friday criticizing his Democratic opponent Sen. Jeanne Shaheen, D-N.H., for "waffling" on a travel ban. In another troubling sign for Democrats, the results of a Gallup poll released on Friday show that Tea Party Republicans are much more motivated to vote in the upcoming midterm elections than other Americans. The poll found that 73 percent of Tea Party Republicans are "extremely" or "very" motivated to vote in this year's elections.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.